Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis
2016 · SpringerPlus · 37 citations
https://doi.org/10.1186/s40064-016-2093-9
S
Shenglin Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
731
Citations
14
h-index
18
i10-index
Shenglin Ma is an academic researcher from Shenzhen University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Mechanisms and Therapy & Cancer-related Molecular Pathways. The author has an h-index of 14, co-authored 47 publications.
ORCID: 0000-0003-4138-0305Papers by this author
worksEndogenous Human CaMKII Inhibitory Protein Suppresses Tumor Growth by Inducing Cell Cycle Arrest and Apoptosis through Down-regulation of the Phosphatidylinositide 3-Kinase/Akt/HDM2 Pathway
2009 · Journal of Biological Chemistry · 35 citations
https://doi.org/10.1074/jbc.m109.028621
Phase 1 Study of the Selective c-MET Inhibitor, HS-10241, in Patients With Advanced Solid Tumors
2022 · JTO Clinical and Research Reports · 4 citations
https://doi.org/10.1016/j.jtocrr.2022.100449
Study on Gene Single Nucleotide Polymorphisms in Han and Uygur Patients With Obstructive Sleep Apnea Hypertension
2025 · American Journal of Respiratory and Critical Care Medicine · 0 citations
https://doi.org/10.1164/ajrccm.2025.211.abstracts.a2713
1742P Adaptive feature optimization algorithm (AFOA) enhances methylation-based early detection in gastric and lung cancer
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.2371
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat